These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37940395)

  • 21. Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine.
    Viboud C; Gostic K; Nelson MI; Price GE; Perofsky A; Sun K; Sequeira Trovão N; Cowling BJ; Epstein SL; Spiro DJ
    PLoS Pathog; 2020 Sep; 16(9):e1008583. PubMed ID: 32970783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines.
    Krammer F; Weir JP; Engelhardt O; Katz JM; Cox RJ
    Influenza Other Respir Viruses; 2020 Mar; 14(2):237-243. PubMed ID: 31837101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in development of the influenza vaccine with broader cross-protection.
    Stropkovská A; Janulíková J; Varecková E
    Acta Virol; 2010; 54(1):7-19. PubMed ID: 20201609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine.
    Tchilian E; Holzer B
    Viruses; 2017 May; 9(5):. PubMed ID: 28475122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus.
    Wong PT; Goff PH; Sun RJ; Ruge MJ; Ermler ME; Sebring A; O'Konek JJ; Landers JJ; Janczak KW; Sun W; Baker JR
    Mol Pharm; 2021 Feb; 18(2):679-698. PubMed ID: 32491861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.
    Matsuda K; Migueles SA; Huang J; Bolkhovitinov L; Stuccio S; Griesman T; Pullano AA; Kang BH; Ishida E; Zimmerman M; Kashyap N; Martins KM; Stadlbauer D; Pederson J; Patamawenu A; Wright N; Shofner T; Evans S; Liang CJ; Candia J; Biancotto A; Fantoni G; Poole A; Smith J; Alexander J; Gurwith M; Krammer F; Connors M
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33529172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies.
    Keating R; Johnson JL; Brice DC; Labombarde JG; Dent AL; McGargill MA
    mBio; 2020 Nov; 11(6):. PubMed ID: 33144374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next generation live-attenuated influenza vaccine platforms.
    Ullah S; Ross TM
    Expert Rev Vaccines; 2022 Aug; 21(8):1097-1110. PubMed ID: 35502639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.
    Krammer F; Palese P; Steel J
    Curr Top Microbiol Immunol; 2015; 386():301-21. PubMed ID: 25007847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential for a Universal Influenza Vaccine.
    Crowe JE
    Cold Spring Harb Perspect Biol; 2018 Jul; 10(7):. PubMed ID: 28663208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine Cross-Reactive Nonneutralizing Polyclonal IgG1 Antibodies Induced by Influenza Vaccine Inhibit the Cross-Protective Effect of IgG2 against Heterologous Virus in Mice.
    Shibuya M; Aoshi T; Kuroda E; Yoshioka Y
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32269125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.
    Karlsson EA; Hertz T; Johnson C; Mehle A; Krammer F; Schultz-Cherry S
    mBio; 2016 Aug; 7(4):. PubMed ID: 27486196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine.
    Fox A; Quinn KM; Subbarao K
    Drugs; 2018 Sep; 78(13):1297-1308. PubMed ID: 30088204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccine: progress in a vaccine that elicits a broad immune response.
    Isakova-Sivak I; Stepanova E; Mezhenskaya D; Matyushenko V; Prokopenko P; Sychev I; Wong PF; Rudenko L
    Expert Rev Vaccines; 2021 Sep; 20(9):1097-1112. PubMed ID: 34348561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Universal Influenza Vaccine Approaches Using Full-Length or Head-Only Hemagglutinin Proteins.
    Ross TM
    J Infect Dis; 2019 Apr; 219(Suppl_1):S57-S61. PubMed ID: 30715379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection.
    Kim YH; Bang YJ; Park HJ; Li Ko H; Park SI; Hwang KA; Kim H; Nam JH
    Vaccine; 2020 Sep; 38(39):6141-6152. PubMed ID: 32739118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.
    Matsuoka Y; Suguitan A; Orandle M; Paskel M; Boonnak K; Gardner DJ; Feldmann F; Feldmann H; Marino M; Jin H; Kemble G; Subbarao K
    J Virol; 2014 Jul; 88(14):8139-52. PubMed ID: 24807726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seasonal influenza vaccines and hurdles to mutual protection.
    Chiu C
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S113-S119. PubMed ID: 27568914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.